Publication | Closed Access

PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer

Pd-1/pd-l1 BlockadeCancer ImmunosurveillanceImmunologyTherapeutic VaccineImmune Checkpoint InhibitorTumor TargetingImmunotherapyMedicineRadiation Oncology